Compare MNKD & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNKD | BBN |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 993.0M |
| IPO Year | 2004 | N/A |
| Metric | MNKD | BBN |
|---|---|---|
| Price | $3.98 | $16.09 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $8.69 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 130.1K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $348,966,000.00 | N/A |
| Revenue This Year | $35.81 | N/A |
| Revenue Next Year | $11.89 | N/A |
| P/E Ratio | $142.75 | ★ N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $15.38 |
| 52 Week High | $6.51 | $17.45 |
| Indicator | MNKD | BBN |
|---|---|---|
| Relative Strength Index (RSI) | 79.50 | 46.62 |
| Support Level | $3.39 | $16.06 |
| Resistance Level | $6.21 | $16.69 |
| Average True Range (ATR) | 0.18 | 0.15 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 83.24 | 21.05 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objectives by investing in a portfolio of taxable municipal securities, including Build America Bonds (BABs), issued by state and local governments to finance capital projects such as public schools, roads, transportation infrastructure, bridges, ports and public buildings.